You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

margetuximab

Showing 1 - 3 of 3
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Metastatic Breast Cancer, Advanced Breast Cancer, HER2-positive Breast Cancer Trial (Margetuximab, Tucatinib, Capecitabine)

Withdrawn
  • Metastatic Breast Cancer
  • +2 more
  • Margetuximab
  • +2 more
  • (no location specified)
Jul 6, 2022

Breast Cancer Metastatic Trial in Taipei (Margetuximab, Trastuzumab, Chosen Chemotherapy (Capecitabine))

Unknown status
  • Breast Cancer Metastatic
  • Margetuximab
  • +4 more
  • Taipei, Taiwan
    National Taiwan University Hospital
Feb 6, 2020

HER-2 Positive Breast Cancer, Metastatic Tumor Trial in Worldwide (Margetuximab, Trastuzumab, Capecitabine)

Active, not recruiting
  • HER-2 Positive Breast Cancer
  • Metastatic Neoplasm
  • Margetuximab
  • +5 more
  • Chandler, Arizona
  • +166 more
Oct 18, 2021